Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotes
Open Access
- 1 November 2007
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 120 (5), 1178-1185
- https://doi.org/10.1016/j.jaci.2007.10.001
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)Journal of Clinical Investigation, 2007
- Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiencyNature Genetics, 2007
- TACI regulates IgA production by APRIL in collaboration with HSPGBlood, 2006
- Monogenetic defects in common variable immunodeficiency: what can we learn about terminal B cell differentiation?Current Opinion in Rheumatology, 2006
- Selective activation of TACI by syndecan-2Blood, 2006
- Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotypeBritish Journal of Haematology, 2006
- Identification of proteoglycans as the APRIL-specific binding partnersThe Journal of Experimental Medicine, 2005
- The Crystal Structure of A Proliferation-inducing Ligand, APRILJournal of Molecular Biology, 2004
- DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILNature Immunology, 2002
- Absence of Memory B Cells in Patients with Common Variable ImmunodeficiencyClinical Immunology, 2002